Prof. AZİZ KARAOĞLU

Publication Network

Journal articles indexed in SCI, SSCI, and AHCI

THSD7A as a novel prognostic factor for colorectal carcinoma

AKTEPE O. H., KURTULAN O., DAMA P. E., ARSLAN A. M., Atag E., ÜNER M., et al.

BMC GASTROENTEROLOGY , no.1, 2025 (SCI-Expanded)

Blood-based biomarkers of frailty in older patients with cancer

Akagunduz B., Ergün Y., Akagündüz D. D., Akbaş N., Akagündüz D., KARAOĞLU A., et al.

Current Opinion in Supportive and Palliative Care , vol.19, no.1, pp.25-32, 2025 (SCI-Expanded)

High Creatinine Level Secondary to Use of CDK 4/6 Inhibitor Treatment (Palbociclib and Ribociclib) + Endocrine Therapy (ET)

KESKİNKILIÇ M., SEMİZ H. S., YAVUZŞEN T., KARAOĞLU A.

Journal of the College of Physicians and Surgeons Pakistan , vol.34, no.7, pp.851-853, 2024 (SCI-Expanded)

The Prognostic Impact of Splenectomy in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

BİŞGİN T., SÖKMEN S., AVKAN OĞUZ V., Obuz F., KARAOĞLU A., ELLİDOKUZ H., et al.

Indian Journal of Surgery , vol.85, no.3, pp.495-501, 2023 (SCI-Expanded) Sustainable Development

CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early-stage prostate carcinoma

Semiz H. S., Kucuk U., Kisa E., Keskinkılıç M., Suyun D. E., Arayici M. E., et al.

PROSTATE , vol.82, no.16, pp.1564-1571, 2022 (SCI-Expanded) Sustainable Development

Increased blood creatinine level due to CDK 4/6 inhibitor treatments: Single center experience

KESKİNKILIÇ M., SEMİZ H. S., YAVUZŞEN T., KARAOĞLU A.

ANNALS OF ONCOLOGY , vol.33, 2022 (SCI-Expanded)

Evaluation of hereditary/familial breast cancer patients with multigene targeted next generation sequencing panel and MLPA analysis in Turkey

Bora E., Caglayan A. O., Koc A., Cankaya T., Ozkalayci H., Kocabey M., et al.

Cancer Genetics , vol.262-263, pp.118-133, 2022 (SCI-Expanded)

Clinical Significance of the Immune Prognostic Index in Patients with Endometrial Carcinoma

ERGÜN B., ÜNEK İ. T., SEMİZ H. S., Saatli B., Alicikus Z. A., BARLIK F., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.32, no.4, pp.222-230, 2022 (SCI-Expanded) Sustainable Development

Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate cancer in geriatric (>= 75) patients

Alkan A., GÜÇ Z. G., Gurbuz M., ozgun G., Degirmencioglu S., Dogan M., et al.

JOURNAL OF MENS HEALTH , vol.17, no.4, pp.128-134, 2021 (SCI-Expanded) Sustainable Development

GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

Peled N., Gillis R., KILIÇKAP S., Froesch P., Orlov S., Filippova E., et al.

LUNG CANCER , vol.148, pp.48-54, 2020 (SCI-Expanded)

GERIATRIC ONCOLOGY PREFACE

IŞIK A. T., KARAOĞLU A.

TIBBI ONKOLOJI - GERIATRIK ONKOLOJI , 2020 (SCI-Expanded)

Prevalence of depressive symptoms in elderly cancer patients receiving chemotherapy and influencing factors

Atag E., Mutlay F., Soysal P., Semiz H. S., KAZAZ S. N., Keser M., et al.

PSYCHOGERIATRICS , vol.18, no.5, pp.365-370, 2018 (SCI-Expanded) Sustainable Development

Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)

ÖZASLAN E., ÖZKAN M., ÇİÇİN İ., BENEKLİ M., Kocer M., UYSAL M., et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , vol.24, no.6, pp.973-979, 2018 (SCI-Expanded)

Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer?

Arslan N. C., BİŞGİN T., ALTAY C., YAVUZŞEN T., KARAOĞLU A., Canda A. E., et al.

JOURNAL OF BUON , vol.23, 2018 (SCI-Expanded) Sustainable Development

A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey - NOTES study

YALÇIN Ş., YILDIZ R., DANE F., KARAOĞLU A., Oksuzoglu B., ÖZYILKAN Ö., et al.

ONCOTARGETS AND THERAPY , vol.11, pp.1223-1228, 2018 (SCI-Expanded)

Response to Cabazitaxel Beyond 20 Cycles in A Patient with Penile Metastasis of Prostate Cancer: A Case Report

Atag E., Semiz H. S., KAZAZ S. N., Tuna E. B., Ozdogan Ö., Bozkurt O., et al.

UROLOGY JOURNAL , vol.14, no.1, pp.2985-2988, 2017 (SCI-Expanded) Sustainable Development

The Rate of Neoadjuvant Chemotherapy Use in Muscle Invasive Bladder Cancer and The Approach of Urologists in Turkey

ÜÇER O., Albaz A. C., Atag E., KARAOĞLU A., MÜEZZİNOĞLU T.

UROLOGY JOURNAL , vol.13, no.5, pp.2841-2844, 2016 (SCI-Expanded) Sustainable Development

Clinicopathological Data's of Advanced NSCLC Patients with ROS1 Gene Rearrangement and of Clinical Responses to Crizotinib in TURKEY

ÖZ A. B., BATUR Ş., Eralp Y., Hasturk S., Yumuk F., Yildiz O., et al.

JOURNAL OF THORACIC ONCOLOGY , vol.10, no.9, 2015 (SCI-Expanded)

Protective role of selenium and high dose vitamin E against cisplatin - induced Nephrotoxicty in rats

Aksoy A., KARAOĞLU A., AKPOLAT N., NAZIROĞLU M., Ozturk T., Karagoz Z. K.

Asian Pacific Journal of Cancer Prevention , vol.16, no.16, pp.6877-6882, 2015 (SCI-Expanded)

The effect of octreotide, an analog of somatostatin, on bleomycin-induced interstitial pulmonary fibrosis in rats

Tug T., KARA H., Karaoglu A., Karatas F., Turgut N. H., Ayan E., et al.

DRUG AND CHEMICAL TOXICOLOGY , vol.36, no.2, pp.181-186, 2013 (SCI-Expanded)

Human telomerase reverse transcriptase expression in colorectal tumors: correlations with immunohistochemical expression and clinicopathologic features

Simsek B. C., Pehlivan S., KARAOĞLU A.

ANNALS OF DIAGNOSTIC PATHOLOGY , vol.14, no.6, pp.413-417, 2010 (SCI-Expanded) Sustainable Development

Malignancies Diagnosed During Pregnancy and Treated With Chemotherapy or Other Modalities (Review of 27 Cases) Multicenter Experiences

Ustaalioglu B. B. O., Gumus M., ÜNAL A., Cayir K., Sever O., Bilici A., et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.20, no.5, pp.698-703, 2010 (SCI-Expanded) Sustainable Development

Ghrelin and obestatin expression in oral squamous cell carcinoma: an immunohistochemical and biochemical study

Alnema M. M., Aydin S., Ozkan Y., Dagli A. F., Ozercan H. I., Yildirim N., et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.339, no.1-2, pp.173-179, 2010 (SCI-Expanded) Sustainable Development

Protective effect of octreotide on intra-tracheal bleomycin-induced oxidative damage in rats

KARA H., Karatas F., Tug T., CANATAN H., Karaoglu A.

EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY , vol.62, no.3, pp.235-241, 2010 (SCI-Expanded)

Expression of obestatin and ghrelin in papillary thyroid carcinoma

Karaoglu A., Aydin S., Dagli A. F., Cummings D. E., Ozercan I. H., CANATAN H., et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.323, no.1-2, pp.113-118, 2009 (SCI-Expanded) Sustainable Development

Uterine primitive neuroectodermal tumor: a case report

Celik H., Gurates B., Karaoglu A., Yavuz A., Dagli F., Ozercan R.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS , vol.279, no.2, pp.259-261, 2009 (SCI-Expanded)

Efficacy and Toxicity of Gemcitabine and Pegylated Liposomal Doxorubicin in Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer

Karaoglu A., Arslan U. Y., ÖZKAN M., Kalender M. E., Alici S., Coskun U., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.10, no.1, pp.63-66, 2009 (SCI-Expanded) Sustainable Development

Ghrelin expression in normal kidney tissue and renal carcinomas

Dagli A. F., Aydin S., Karaoglu A., Akpolat N., Ozercan I. H., Ozercan M. R.

PATHOLOGY RESEARCH AND PRACTICE , vol.205, no.3, pp.165-173, 2009 (SCI-Expanded) Sustainable Development

Primary mucinous adenocarcinoma of appendix treated with chemotherapy and radiotherapy: a case report

Topkan E., Polat Y., Karaoglu A.

TUMORI , vol.94, no.4, pp.596-599, 2008 (SCI-Expanded)

Localized Palmar-Plantar Epidermal Hyperplasia Associated with Use of Sorafenib

Cicek D., Kandi B., Dagli F. A., Karaogiu A., Haligur B. D.

CLINICAL DRUG INVESTIGATION , vol.28, no.12, pp.803-807, 2008 (SCI-Expanded)

Urine calcium and deoxypyridinoline in assessment of response to local radiation therapy for metastatic bone disease

TOPKAN E., KARAOĞLU A.

Journal of Experimental & Clinical Cancer Research , vol.26, no.4, pp.553-559, 2007 (SCI-Expanded)

Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population

ELKIRAN E. T., Mar N., Aygen B., Gursu F., Karaoglu A., Koca S.

BMC CANCER , vol.7, 2007 (SCI-Expanded) Sustainable Development

Ghrelin: A novel peptide with therapeutic effect in certain cancers?

Aydin S., GEÇKİL H., Karaoglu A., ELKIRAN E. T.

MEDICAL HYPOTHESES , vol.69, no.5, pp.1157-1158, 2007 (SCI-Expanded) Sustainable Development

Incidental DTPA and DMSA uptake during renal scanning in unknown bone metastases

Balci T. A., Ciftci I., Karaoglu A.

ANNALS OF NUCLEAR MEDICINE , vol.20, no.5, pp.365-369, 2006 (SCI-Expanded)

Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma

Topkan E., Karaoglu A.

ONCOLOGY , vol.71, no.5-6, pp.354-360, 2006 (SCI-Expanded) Sustainable Development

Metastatic osteosarcoma to the brain in adult patient

ELKIRAN E. T., Aygen B., Karaoglu A., Altundag K.

JOURNAL OF NEURO-ONCOLOGY , vol.76, no.2, pp.213, 2006 (SCI-Expanded)

Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats

Atessahin A., Yilmaz S., Karahan I., Ceribasi A., Karaoglu A.

TOXICOLOGY , vol.212, no.2-3, pp.116-123, 2005 (SCI-Expanded)

A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer

Erman M., Baltali E., Karaoglu A., Abali H., Engin H., Ozisik Y., et al.

CANCER INVESTIGATION , vol.23, no.3, pp.215-221, 2005 (SCI-Expanded) Sustainable Development

Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats

Naziroglu M., Karaoglu A., Aksoy A.

TOXICOLOGY , vol.195, no.2-3, pp.221-230, 2004 (SCI-Expanded) Sustainable Development

Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors

Karaoglu A., Yalcin S., Tekuzman G., Kars A., Celik I., Guler N., et al.

TUMORI , vol.89, no.2, pp.141-145, 2003 (SCI-Expanded) Sustainable Development

Solitary esophageal metastasis of breast cancer after 11 years

Erman M., Karaoglu A., Oksuzoglu B., AYDINGÖZ Ü., Ayhan A., Guler N.

MEDICAL ONCOLOGY , vol.19, no.3, pp.171-175, 2002 (SCI-Expanded) Sustainable Development

Articles Published in Other Journals

Endogenous Endophthalmitis Caused by Aspergillus lentulus in an Immunocompromised Patient with Lung Cancer

Kayabaşı M., AYHAN Z., LEBE B., ÖZKÜTÜK A. A., Bajin M. S., NAZLI A., et al.

Turkish Journal of Ophthalmology , vol.54, no.3, pp.175-179, 2024 (Scopus)

ERDAFITINIB-INDUCED BILATERAL MULTIFOCAL SEROUS RETINAL DETACHMENTS AND SEVERE DRY EYE RELATED UNILATERAL PERIPHERAL ULCERATIVE KERATITIS IN A PATIENT WITH METASTATIC UROTHELIAL CARCINOMA

Kayabaşı M., Görken İ. B., DURAK İ., KARAOĞLU A., SAATCİ A. O.

European Journal of Case Reports in Internal Medicine , vol.11, no.6, 2024 (Scopus)

Examination of Factors Affecting Prognosis and Treatment Choice in Patients with Endometrial Cancer: A Retrospective Single-Center Experience

Uzun M., USUBBAYLI A., Çalişkan Yildirim E., KARAOĞLU A.

Journal of Oncological Science , vol.9, no.3, pp.121-127, 2023 (Scopus)

Does Mammographic Density Predict Pathological Complete Response in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy?

UZUN M., Kurtuluş E., ÇALIŞKAN YILDIRIM E., ÜNEK İ. T., SEMİZ H. S., ELLEZ H. İ., et al.

Eurasian Journal of Medical Investigation , vol.7, no.2, 2023 (Peer-Reviewed Journal)

Metastatik Renal Hücreli Kanser Hastalarında Genel Sağkalım Üzerine Etkili Faktörlerin İncelenmesi: Dokuz Eylül Üniversitesi Tıbbi Onkoloji Kliniği Örneği

uzun m., Caliskan Yildirim E., EKİNCİ F., Demir B., ERDOĞAN A. P., KARAOĞLU A., et al.

Batı Karadeniz Tıp Degisi , vol.6, no.2, pp.165-171, 2022 (Peer-Reviewed Journal)

What Is Your Choice for Androgen Deprivation Therapy in Metastatic Prostate Carcinoma: Surgical or Medical?

Semiz H. S., Kisa E., Caliskan Yildirim E., Atag E., Arayici M. E., Muezzinoglu T., et al.

Turkish journal of urology , vol.48, no.4, pp.287-293, 2022 (ESCI)

APPROACH TO THE TREATMENT OF METASTATIC CASTRATION-SENSITIVE PROSTATE CARCINOMA: A SINGLE CENTER EXPERIENCE

SEMİZ H. S., KESKİNKILIÇ M., ELLEZ H. İ., Arayici M. E., KARAOĞLU A.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , vol.6, no.1, pp.296-304, 2022 (ESCI) Sustainable Development

Turkish society of medical oncology covid-19 pandemic advisory board updated recommendations for medical oncologists: Included vaccination

Sümbül A. T., YALÇIN S. S., ÖZET A., ÜNAL S., DİZDAR Ö., AKBULUT H., et al.

Journal of Oncological Science , vol.7, no.1, pp.1-6, 2021 (Scopus)

Alteration of saliva and blood ghrelin, obestatin, leptin and weight based on adjuvant chemotherapy treatment in early-stage operated breast cancer patients

Yılmaz N., Karaoğlu A., Ugur K., Yardım M., Aydın S.

Annals of Medical Research , vol.27, no.3, pp.913-920, 2020 (Peer-Reviewed Journal) Sustainable Development

Geriatrik Hastalarda Meme Kanseri

GÜÇ Z. G., ÇETİNAYAK H. O., SEVİNÇ A. İ., KARAOĞLU A.

Turkiye Klinikleri J Med Oncol-Special Topics , vol.11, no.1, pp.75-81, 2018 (Peer-Reviewed Journal) Sustainable Development

Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer

Atag E., KARAOĞLU A., Kucuk O.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.16, no.2, pp.57-62, 2017 (ESCI) Sustainable Development

Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer

Atağ E., Karaoğlu A., Küçük Ö.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.16, no.2, pp.57-62, 2017 (Peer-Reviewed Journal) Sustainable Development

Case Report of a Renal Cell Carcinoma Patient with Acute Pancreatitis Under Both Sunitinib and Axitinib Treatment

OFLAZOĞLU U., VAROL U., ALACACIOĞLU A., SALMAN T., DEMİR N., SEMİZ H. S., et al.

Journal of oncological sciences , vol.2, no.2, pp.63-65, 2016 (Peer-Reviewed Journal)

Cutaneous changes in patients with internal malignancies

Dertlioğlu Bakar S., Demir B., Karaoğlu A., Uçak H.

Dicle Tıp Dergisi , vol.40, no.4, pp.637-640, 2013 (Peer-Reviewed Journal)

The levels of urine calcium and deoxypyridinoline in patients with metastatic bone disease treated with palliative radiotherapy

Topkan E., Özyiğit G., Gülbaş H., Karaoğlu A.

Türk Hematoloji Onkoloji Dergisi , vol.14, no.4, pp.200-204, 2004 (Peer-Reviewed Journal) Sustainable Development

Retrospective evaluation of operated stage I breast cancer patients

ÇAKMAK ÖKSÜZOĞLU Ö. B., Güler N., Baltalı E., KARAOĞLU A., ÖZIŞIK Y. Y., ALTUNDAĞ M. K., et al.

Turkish Journal Of Cancer , vol.33, pp.40-50, 2003 (Peer-Reviewed Journal) Sustainable Development

Familial asynchronous bilateral primary male breast carcinoma

KARAOĞLU A., Altundağ M. K., AYDINGÖZ Ü., ERMAN M., ENGİN H., GÜLLÜ İ. H.

Journal of experimental & clinical cancer research , vol.21, no.1, pp.143-144, 2002 (Peer-Reviewed Journal)

Obesity and the activity of the autonomic nervous system

Çolak R., Dönder E., Karaoğlu A., Ayhan O., Yalnız M.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.30, no.2, pp.173-176, 2000 (Scopus) Sustainable Development

Hiperlipidemik tip II dibetes mellituslu olgularda balık yağının lipid profili ve glukoz kontrolü üzerine etkileri

KARAOĞLU A., Doğan H., ÜSTÜNDAĞ B., Özkan Y., DÖNDER E.

Göztepe Tıp Dergisi , 2000 (Peer-Reviewed Journal)

Peptik ülser ve gastrite bağlı kanama sonrasında omeprazol ve ranitidin tedavisinin etkinliği

KARAOĞLU A., ÇOLAK R., Çelebi H., Zülfikar G., DÖNDER E.

Ege Tıp Dergisi , 1998 (Peer-Reviewed Journal)

Papers Presented at Peer-Reviewed Scientific Conferences

Achieving treatment goals in elderly breast cancer patients with neoadjuvant chemotherapy: A remarkable insight

Yildirim E. C., SEMİZ H. S., Unal O. U., Atag E., KARAOĞLU A.

Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 20 - 24 October 2023 Sustainable Development

Metastatik mesane kanseri tanili hastalarda prognosu etkileyen faktörlerin incelenmesi;tek merkez deneyimi

Gökçek S., Uzun M., Karaoğlu A.

5.geriatrik onkoloji kongresi, Antalya, Turkey, 25 - 27 November 2022, pp.9-12, (Summary Text) Sustainable Development

Sınırlı ve Yaygın Evre Küçük Hücreli Akciğer Kanserinde Sistemik Enflamasyon Yanıt İndeksi ile Prognoz Arası İlişki

Uzun M., Karaoğlu A.

6.immünoterapi ve onkoloji kongresi, Antalya, Turkey, 19 - 23 October 2022, pp.4-5, (Summary Text)

Metastatik Hormon Duyarlı Prostat Karsinomu’nda Prognozu Öngörmede CHAARTED ve LATITUDE Kriterlerinin Karşılaştırılması

Ellez H. İ., Semiz H. S., Ünal O. Ü., Karaoğlu A.

6. İmmunoloji ve Onkoloji Kongresi, Antalya, Turkey, 19 - 23 October 2022, pp.48, (Summary Text)

The Increased Creatinine Level Secondary to Use of CDK 4/6 Inhibitor and Endocrine Therapy: Real Life Data

Keskinkılıç M., Semiz H. S., Yavuzşen T., Karaoğlu A.

Breastanbul, İstanbul, Turkey, 13 - 15 October 2022, pp.55

The relationship between mamographic density and pathological respoınse in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy

Çalışkan Yıldırım E., Uzun M., Karaoğlu A.

Breastanbul, İstanbul, Turkey, 13 - 15 October 2022, pp.83-84 Sustainable Development

Kastrasyon Sensitif Metastatik Prostat Karsinomu’nda Kemoterapi ve Lu-177 PSMA ile 46 Aylık Hastalıksız Sağkalım

ELLEZ H. İ., BEKİŞ R., SEMİZ H. S., KARAOĞLU A.

9. Türk Tıbbi Onkoloji Kongresi, Girne, Cyprus (Kktc), 18 - 22 May 2022

Türkiye’de Üroloji ve Onkoloji Hekimlerinin Prostat Karsinomunda Orşiektomi Hakkındaki Tutumları

SEMİZ H. S., KISA E., ÇALIŞKAN YILDIRIM E., ATAĞ E., ARAYICI M. E., MÜEZZİNOĞLU T., et al.

9. Türk Tıbbi Onkoloji Kongresi, Girne, Cyprus (Kktc), 18 - 22 May 2022, (Summary Text)

ERLOTINIB KULLANIMI SONRASI GELIŞEN ŞIDDETLI BIR PAPÜLOPÜSTÜLER CILT TOKSISITESI OLGUSU

Gökçek S., Ellez H. İ., Uzun M., Karaoğlu A.

9. Türk Tıbbi Onkoloji Derneği Kongresi, Girne, Cyprus (Kktc), 18 - 22 May 2022, pp.132, (Full Text)

KASTRASYON SENSITIF METASTATIK PROSTAT KARSINOMU’NDA KEMOTERAPI VE LU-177 PSMA ILE 46 AYLIK HASTALIKSIZ SAĞKALIM

Ellez H. İ., Semiz H. S., Karaoğlu A.

9. Türk Tıbbi Onkoloji Derneği Kongresi, Girne, Cyprus (Kktc), 18 - 22 May 2022, pp.225 Sustainable Development

Increased Blood Creatinine Level due to CDK 4/6 Inhibitor Treatments: Single Center Experience

KESKİNKILIÇ M., SEMİZ H. S., YAVUZŞEN T., KARAOĞLU A.

Esmo Breast Congress 2022, Berlin, Germany, 30 September - 01 October 2022, vol.33, pp.216, (Summary Text)

Nadir Görülen ve Everolimus Tedavisine Yanıtlı Malign Epiteloid Anjiyomyolipom Olgusu

Keskinkılıç M., Karaoğlu A.

8. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 3 - 07 November 2021, pp.25, (Full Text)

ATEŞ, ÇARPINTI, ARTRALJİ : KARDİYAK METASTAZ BELİRTİSİ OLABİLİR Mİ?

Uzun M., Çalışkan Yıldırım E., Karaoğlu A.

8.TÜRK TIBBİ ONKOLOJİ KONGRESİ, Antalya, Turkey, 3 - 07 November 2021, pp.72, (Full Text) Sustainable Development

CDK 4/6 İnhibitor Kullanımına Bağlı Nefrotoksisite Gelişen 3 (Üç) Olgu

Keskinkılıç M., Uzun M., Çalışkan Yıldırım E., Karaoğlu A.

5.Ulusal İmmunoterapi ve Onkoloji Kongresi, Antalya, Turkey, 13 - 17 October 2021, pp.10-11, (Full Text)

Tanı Anında Metastatik Olan Mesane Kanseri Tanılı Geriatrik Yaş Grubundaki Hastaların Değerlendirilmesi : Tek Merkez Deneyimi

Keskinkılıç M., Karaoğlu A.

4. Geriatrik Onkoloji Kongresi, İzmir, Turkey, 12 - 13 December 2020, pp.18-19

Is splenectomy a prognostic factor for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis (PM)?

Bisgin T., Sökmen S., Canda A., Avkan Oğuz V., Barlık Obuz F., Karaoğlu A., et al.

The 30th Biennial Congress of ISUCRS 2020, Ageo, Japan, 17 - 19 June 2020, pp.25

Is Enzalutamide Safe in Patients with Metastatic Prostate Carcinoma Undergoing Hemodialysis?

SEMİZ H. S., AKAGÜNDÜZ B., ATAĞ E., KARAOĞLU A.

3th National Immunotherapy and Oncology Congress, Antalya, Turkey, 30 October - 03 November 2019

Metastatik Nöroendokrin Tümör Tanılı Hastada Refrakter Hiperamonyemi

ŞENCAN C., ÜNAL S., AKAGÜNDÜZ B., ÖZER Ö., KARAOĞLU A.

23. Ulusal Kanser Kongresi, Antalya, Turkey, 17 - 21 April 2019, (Summary Text)

Nutrition-aware treatment approach has a prognostic impact in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

SÖKMEN S., BİŞGİN T., ARSLAN N. Ç., AĞALAR C., EGELİ T., ÜNLÜ Ş. M., et al.

40th ESPEN congress, Madrid, Spain, 1 - 04 September 2018, vol.37, pp.78, (Summary Text)

DEGUELIN’S EFFICACY IN in vitro ANTI-CANCER MARKER IN LUNG CANCER

ghanitabe n., çelebi s., CENGİZ H., ATEŞ H., KOÇDOR M. A., KARAOĞLU A., et al.

2. IVD Semp., 10 - 12 May 2017 Sustainable Development

Yaş Kolorektal Kanser Peritoneal Metastazlarında Sitoredüktif Cerrahi ve Hipertermik İntraperitoneal Kemoterapi içinBir Engel mi?

BİŞGİN T., ARSLAN N. Ç., AĞALAR C., CANDA A. E., KARAOĞLU A., OBUZ F., et al.

16. Türk Kolon ve Rektum Cerrahisi Kongresi, Antalya, Turkey, 16 - 20 May 2017, (Summary Text) Sustainable Development

Characteristics of Turkish colorectal cancer patients and bevacizumab preference.

Cicin I., Gumus M., Uncu D., Ozkan M., Kilickap S., ELKIRAN E. T., et al.

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35, (Summary Text) Sustainable Development

Effectiveness and safety of LMWH treatment in patients with cancer diagnosed with nonhigh-risk venous thromboembolism (VTE): Results of the Turkish observational study (TREBECA).

Ozaslan E., Ozkan M., Cicin I., Benekli M., Kocer M., Uysal M., et al.

53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2 - 07 June 2017, vol.35 Sustainable Development

Anti cancer efficacy of deguelin against lungcancer cells

ÇELEBİ S., GHANITABE N., CENGİZ H., ATEŞ H., KOÇDOR M. A., KARAOĞLU A., et al.

1.CELL DEATH CONGRESS, 4 - 07 May 2016, (Summary Text) Sustainable Development

ANTI CANCER EFFICACY OF DEGUELIN AGAINST LUNG CANCER CELLS WITH AND WITHOUT DOCETAXEL

Çelebi S., Ghanitabe N., CENGİZ H., ATEŞ H., KOÇDOR M. A., KARAOĞLU A., et al.

1.Cell Death Congress, 4 - 07 May 2016, (Summary Text) Sustainable Development

Geriatrik Onkoloji Hastalarında Depresyon Sıklığı ve Olası Nedenlerin Belirlenmesi

ATAĞ E., MUTLAY F., SOYSAL P., SEMİZ H. S., KAZAZ S. N., KESER M., et al.

2. Geriatrik Onkoloji Kongresi, Antalya, Turkey, 20 - 23 October 2016

Geriatrik Onkoloji Hastalarında Depresyon Sıklığı ve Olası Nedenlerin Belirlenmesi

Atağ E., Mutlay F., Soysal P., Semiz H. S., Kazaz S. N., Keser M., et al.

2. Geriatrik Onkoloji Kongresi, Antalya, Turkey, 20 - 23 October 2016

Effect of body mass index in gastric cancer patients Analysis of Turkish national gastric cancer registry

Ciltaş A., KARACA M., UNCU D., ÖZKAN M., Aliustaoğlu M., TEKİN S. B., et al.

ASCO ANNUALA MEETING 2015, Chicago, United States Of America, 29 May 2015 - 02 June 2016, (Summary Text) Sustainable Development

Dynamic Correlation of Serum C-Reactive Protein (CRP) Levels with Serum Prostate-Specific Antigen (PSA) Levels in Patients with Prostate Cancer (PCa) on Androgen Deprivation Therapy (ADT)

KÜÇÜK Ö., BALCI B., LIU Y., ZHANG C., YILMAZ B., ATAĞ E., et al.

2016 Genitourinary Cancers Symposium, California, United States Of America, 07 January 2016, vol.34 Sustainable Development

Dynamic correlation of serum C-reactive protein (CRP) levels with serum prostate-specific antigen (PSA) levels in patients with prostate cancer (PCa) on androgen deprivation therapy (ADT).

Kucuk O., Balci B., Liu Y., Zhang C., Yilmaz B., Atag E., et al.

Genitourinary Cancers Symposium, San-Francisco, Costa Rica, 7 - 09 January 2016, vol.34 Sustainable Development

ANTI CANCER EFFICACY OF DEGUELIN AGAINST LUNGCANCER CELLS WITH AND WITHOUT DOCETAKSEL

çelebi s., ghanitabe n., CENGİZ H., ATEŞ H., KOÇDOR M. A., KARAOĞLU A., et al.

27. Ulusal Biyokimya Kongresi, Antalya [27th National Biochemistry Congress, Antalya, 3 - 06 November 2015 Sustainable Development

Low molecular weight heparin LMWH treatment in cancer patients with low risk venous thromboembolism results of Turkish Observational Study TREBECA

ÖZKAN M., ÇİÇİN İ., ÖZASLAN E., BENEKLİ M., ÇAKMAK ÖKSÜZOĞLU Ö. B., IŞIKDOĞAN A., et al.

18th ECCO, 25 - 29 September 2015

Clinicopathological Data s of Advanced NSCLC Patients with ROS1 Gene Rearrangement and of Clinical Responses to Crizotinib in TURKEY

ÖZ A. B., Batur Ş., ERALP Y., Hastürk S., YUMUK P. F., Yılıdz Ö., et al.

16th World Conference on Lung Cancer, 6 - 09 September 2015, (Summary Text)

Turkish National Gastric Cancer Registry

BÜYÜKBERBER S., Dumanlı E., Uncu D., ÖZKAN M., USLU R., GÖKÖZ DOĞU G., et al.

ASCO ANNUAL MEETING 2015, Chicago, United States Of America, 29 May - 02 June 2015, (Summary Text) Sustainable Development

Geographic variations of clinical characteristics in breast cancer Analysis of Turkish National Breast Cancer Registry

KILIÇKAP S., ALTUNDAĞ M. K., Dumanlı E., GÜMÜŞ M., USLU R., ÖZYILKAN Ö., et al.

ASCO ANNUAL MEETING 2015, Chicago, United States Of America, 29 May - 02 June 2015, (Summary Text) Sustainable Development

Turkish National Colon Cancer Registry

BENEKLİ M., Dumanlı E., KILIÇKAP S., Uncu D., Aliustaoğlu M., ÇİÇİN İ., et al.

ASCO ANNUAL MEETING 2015, Chaicago, United States Of America, 29 May - 02 June 2015 Sustainable Development

Association of age with breast cancer clinical and pathological factors Analysis of Turkish National Breast Cancer Registry

BENEKLİ M., ALTUNDAĞ M. K., Dumanlı E., IŞIKDOĞAN A., KARAOĞLU A., TEKİN S. B., et al.

ASCO ANNU(AL MMETING 2015, Chicago, United States Of America, 29 May - 02 June 2015, (Summary Text) Sustainable Development

Association of obesity with breast cancer clinical and pathological factors Analysis of Turkish National Breast Cancer Registry

COŞKUN U., ALTUNDAĞ M. K., Aliustaoğlu M., Uncu D., ÖZKAN M., ÇİÇİN İ., et al.

ASCO ANNUAL MEETING 2015, Chicago, United States Of America, 29 May - 02 June 2015, (Summary Text) Sustainable Development

Turkish National Breast Cancer Registry

ALTUNDAĞ M. K., Dumanlı E., Aliustaoğlu M., Uncu D., ÖZKAN M., ÇİÇİN İ., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -2015, 29 May - 02 June 2015, (Summary Text) Sustainable Development

Bilateral Atrial Fibrosarkom: Olgu Sunumu

KAZAZ S. N., YAMAN D. S., ÜNEK İ. T., ATAĞ E., SEMİZ H. S., DEMİR N., et al.

21. Ulusal Kanser Kongresi, Antalya, Turkey, 22 - 26 April 2015, (Summary Text)

Kabazitaksele Yanıt Veren Penil Metastatik Prostat Adenokarsinoma: Olgu Sunumu

ATAĞ E., KAZAZ S. N., SEMİZ H. S., BOZKURT O., DEMİR Ö., TUNA E. B., et al.

21. Ulusal Kanser Kongresi, Antalya, Turkey, 22 - 26 April 2015

Kolon Kanseri Karaciğer Metastazı Tanılı Olguda Panitumumab Kapesitabin ve Oksaplatin Kombinasyonu P CAPEOX ile Radyolojik Tam Yanıt

KARAOĞLU A., SOMALI I., OBUZ F., ATAĞ E., KAZAZ S. N., BASKIN Y., et al.

21.Ulusal Kanser Kongresi, Antalya (22-26 Nisan 2015) Poster Bildiri, Turkey, 22 - 26 April 2015

Mide Kanserli Hastaların Klinikopatolojik Özelliklerinin Retrospektif Değerlendirilmesi ve Sağkalım ile Korelasyonu

SERT D. A., KAZAZ S. N., SEMİZ H. S., ATAĞ E., OFLAZOĞLU U., DEMİR N., et al.

21. Ulusal Kanser Kongresi, Turkey, 22 - 26 April 2015 Sustainable Development

Metastatik Kolon Kanserli Hastada İkinci Sıra Tedavi Olarak FOLFOXIRI ve Bevasizumab Rejimi

ATAĞ E., SEMİZ H. S., KAZAZ S. N., DEMİR N., OFLAZOĞLU U., ÜNEK İ. T., et al.

21. ULUSAL KANSER KONGRESİ, Turkey, 22 - 26 April 2015 Sustainable Development

Geriatrik Hastada Senkron Mide ve Kolon Adenokarsinomu

ATAĞ E., ÜNEK İ. T., KAZAZ S. N., SEMİZ H. S., OFLAZOĞLU U., DEMİR N., et al.

21. ULUSAL KANSER KONGRESİ, Turkey, 22 - 26 April 2015

Kolon Kanseri Karaciğer Metastazı Tanılı Olguda Panitumumab Kapesitabin ve Oksaliplatin Kombinasyonu P CAPEOX ile Radyolojik Tam Yanıt

Ünek İ. T., Kazaz S. N., Semiz H. S., Atağ E., Oflazoğlu U., Demir N., et al.

7. ULUSAL GASTROİNTESTİNAL ONKOLOJİ KONGRESİ GİOK, Antalya, Turkey, 10 - 12 April 2015, pp.9 Sustainable Development

Senkron gastrik karsinom kolon karsinomu ve renal hücreli karsinom Olgu sunumu

SEMİZ H. S., ATAĞ E., ÜNEK İ. T., DEMİR N., OFLAZOĞLU U., KAZAZ S. N., et al.

7. ULUSAL GASTROİNTESTİNAL ONKOLOJİ KONGRESİ, Turkey, 9 - 12 April 2015

Kolonun Nadir Görülen ve Hızlı Progresyon İzlenen Mikst Adenonöroendokrin Karsinomu MANEK Olgu Sunumu

KAZAZ S. N., ATAĞ E., SEMİZ H. S., OFLAZOĞLU U., DEMİR N., DEMİRKAN H. M. B., et al.

2. NADİR TÜMÖRLER SEMPOZYUMU, Turkey, 27 February - 01 March 2015, vol.5

Metronomik Tedaviye Yanıt Veren Miksoid Liposarkom Olgu Sunumu

KAZAZ S. N., SEMİZ H. S., ATAĞ E., DEMİR N., OFLAZOĞLU U., ÜNEK İ. T., et al.

2. NADİR TÜMÖRLER SEMPOZYUMU, Turkey, 27 February - 01 March 2015

Nadir Bir Tümörün Nadir Bir Prezentasyonu Batın İçi Malign Periferik Sinir Kılıfı Tümörü

ATAĞ E., SEMİZ H. S., KAZAZ S. N., DEMİR N., OFLAZOĞLU U., ÜNEK İ. T., et al.

2. NADİR TÜMÖRLER SEMPOZZYUMU, Turkey, 27 February - 01 March 2015

FOLFOXIRI and Bevacizumab Regimen as a Second-Line Therapy: a Case Report

ATAĞ E., SEMİZ H. S., KAZAZ S. N., DEMİR N., OFLAZOĞLU U., ÜNEK İ. T., et al.

4th International Gastrointestinal Cancer Conference, İstanbul, Turkey, 12 - 14 December 2014

Synchronous Appearence of Gastric Carcinoma, Colon Carcinoma, and Renal Cell Carcinoma: Report of a Case

ATAĞ E., ÜNEK İ. T., DEMİR N., OFLAZOĞLU U., KAZAZ S. N., SEMİZ H. S., et al.

4th International Gasrointestinal Cancer Conferance, İstanbul, Turkey, 12 - 14 December 2014, (Summary Text)

Synchronous Appearance of Gastric Carcinoma, Colon Carcinoma, and Renal Cell Carcinoma: a Case Report

ATAĞ E., ÜNEK İ. T., DEMİR N., OFLAZOĞLU U., KAZAZ S. N., SEMİZ H. S., et al.

4th International Gastrointestinal Cancer Conference, İstanbul, Turkey, 12 - 14 December 2014, (Summary Text)

Geriatrik Meme Kanserli Hastaların Patolojik ve Klinik Özellikleri

ATAĞ E., DEMİR N., OFLAZOĞLU U., KAZAZ S. N., SEMİZ H. S., YAVUZŞEN T., et al.

1. Geriatrik Onkoloji Kongresi ve Geriatrik Onkolojide Moleküler Nutrisyon Sempozyumu, Antalya, Turkey, 16 - 19 October 2014, (Summary Text) Sustainable Development

Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology

Demirci U., Oflazoglu U., Kodaz H., Ciltas A., KEFELİ U., Akyol M., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32 Sustainable Development

Turkish Breast Cancer Registry: A multicenter epidemiologic study

Coskun U., Gumus M., Uncu D., Ozkan M., Cicin I., Altundag K., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32, (Summary Text) Sustainable Development